Ligand Pharmaceuticals, Inc. (LGND)
204.81
-5.68
(-2.70%)
USD |
NASDAQ |
Mar 20, 16:00
204.90
+0.09
(+0.04%)
After-Hours: 20:00
Ligand Pharmaceuticals EPS Diluted (Quarterly) : 2.119 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0054 |
| ADMA Biologics, Inc. | 0.2025 |
| Intuitive Surgical, Inc. | 2.205 |
| Globus Medical, Inc. | 1.029 |
| Establishment Labs Holdings, Inc. | -0.0878 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 44.78M |
| Revenue (Quarterly) | 59.67M |
| Total Expenses (Quarterly) | 14.88M |
| Enterprise Value | 3.802B |
| Gross Profit Margin (Quarterly) | 81.42% |
| Profit Margin (Quarterly) | 75.06% |
| Earnings Yield | 2.85% |
| Operating Earnings Yield | 1.14% |
| Normalized Earnings Yield | 1.506 |